X-9743555-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000273.3(GPR143):​c.767+10C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.216 in 1,012,845 control chromosomes in the GnomAD database, including 17,349 homozygotes. There are 67,243 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 1385 hom., 5467 hem., cov: 22)
Exomes 𝑓: 0.22 ( 15964 hom. 61776 hem. )

Consequence

GPR143
NM_000273.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.347

Publications

6 publications found
Variant links:
Genes affected
GPR143 (HGNC:20145): (G protein-coupled receptor 143) This gene encodes a protein that binds to heterotrimeric G proteins and is targeted to melanosomes in pigment cells. This protein is thought to be involved in intracellular signal transduction mechanisms. Mutations in this gene cause ocular albinism type 1, also referred to as Nettleship-Falls type ocular albinism, a severe visual disorder. A related pseudogene has been identified on chromosome Y. [provided by RefSeq, Dec 2009]
GPR143 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • ocular albinism
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • nystagmus 6, congenital, X-linked
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • X-linked recessive ocular albinism
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-9743555-G-C is Benign according to our data. Variant chrX-9743555-G-C is described in ClinVar as [Benign]. Clinvar id is 255712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.303 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GPR143NM_000273.3 linkc.767+10C>G intron_variant Intron 6 of 8 ENST00000467482.6 NP_000264.2 P51810
GPR143NM_001440781.1 linkc.767+10C>G intron_variant Intron 6 of 8 NP_001427710.1
GPR143XM_024452388.2 linkc.515+10C>G intron_variant Intron 6 of 8 XP_024308156.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GPR143ENST00000467482.6 linkc.767+10C>G intron_variant Intron 6 of 8 1 NM_000273.3 ENSP00000417161.1 P51810
GPR143ENST00000447366.5 linkc.515+10C>G intron_variant Intron 6 of 7 3 ENSP00000390546.2 H7BZN6
GPR143ENST00000431126.1 linkc.*10C>G downstream_gene_variant 3 ENSP00000406138.1 C9J9N1

Frequencies

GnomAD3 genomes
AF:
0.170
AC:
18893
AN:
110810
Hom.:
1384
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0619
Gnomad AMI
AF:
0.243
Gnomad AMR
AF:
0.112
Gnomad ASJ
AF:
0.275
Gnomad EAS
AF:
0.228
Gnomad SAS
AF:
0.320
Gnomad FIN
AF:
0.205
Gnomad MID
AF:
0.242
Gnomad NFE
AF:
0.223
Gnomad OTH
AF:
0.177
GnomAD2 exomes
AF:
0.203
AC:
37159
AN:
182915
AF XY:
0.221
show subpopulations
Gnomad AFR exome
AF:
0.0616
Gnomad AMR exome
AF:
0.0731
Gnomad ASJ exome
AF:
0.285
Gnomad EAS exome
AF:
0.238
Gnomad FIN exome
AF:
0.210
Gnomad NFE exome
AF:
0.224
Gnomad OTH exome
AF:
0.214
GnomAD4 exome
AF:
0.222
AC:
200283
AN:
901983
Hom.:
15964
Cov.:
17
AF XY:
0.235
AC XY:
61776
AN XY:
263049
show subpopulations
African (AFR)
AF:
0.0632
AC:
1430
AN:
22610
American (AMR)
AF:
0.0813
AC:
2844
AN:
34964
Ashkenazi Jewish (ASJ)
AF:
0.281
AC:
5115
AN:
18203
East Asian (EAS)
AF:
0.221
AC:
6482
AN:
29338
South Asian (SAS)
AF:
0.324
AC:
16242
AN:
50139
European-Finnish (FIN)
AF:
0.210
AC:
8506
AN:
40411
Middle Eastern (MID)
AF:
0.289
AC:
1075
AN:
3720
European-Non Finnish (NFE)
AF:
0.226
AC:
149940
AN:
663098
Other (OTH)
AF:
0.219
AC:
8649
AN:
39500
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
5715
11430
17144
22859
28574
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4882
9764
14646
19528
24410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.170
AC:
18892
AN:
110862
Hom.:
1385
Cov.:
22
AF XY:
0.165
AC XY:
5467
AN XY:
33134
show subpopulations
African (AFR)
AF:
0.0619
AC:
1894
AN:
30606
American (AMR)
AF:
0.112
AC:
1162
AN:
10376
Ashkenazi Jewish (ASJ)
AF:
0.275
AC:
724
AN:
2629
East Asian (EAS)
AF:
0.228
AC:
795
AN:
3486
South Asian (SAS)
AF:
0.321
AC:
840
AN:
2615
European-Finnish (FIN)
AF:
0.205
AC:
1203
AN:
5857
Middle Eastern (MID)
AF:
0.251
AC:
55
AN:
219
European-Non Finnish (NFE)
AF:
0.223
AC:
11790
AN:
52896
Other (OTH)
AF:
0.177
AC:
266
AN:
1507
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
573
1147
1720
2294
2867
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.147
Hom.:
1180
Bravo
AF:
0.158

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ocular albinism, type I Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nystagmus 6, congenital, X-linked Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
7.1
DANN
Benign
0.38
PhyloP100
-0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3788938; hg19: chrX-9711595; API